Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study.

"Declarations Ethics approval and consent to participateThe study was approved by the research ethics committee of the First People’s Hospital of Huaihua (No. KY-2019082203). Informed consent was obtained from all study participants and the study was carried out in accordance with relevant guidelines and regulations (e.g. Declaration of Helsinki). Consent for publicationNot applicable. Competing interestsAll authors declare no Competing interests. Competing interests All authors declare no Competing interests."

"Funding This research was funded by the National Natural Science Foundation of China [grant numbers 82160075]; the Natural Science Foundation of Hunan Province, CN [grant numbers 2019JJ40230, 2020JJ4072, 2021JJ30534]; the Health Commission Program of Hunan province, CN [grant numbers B2019034, B2019035, B202303018485, 202113011165]; the Science and Technology Plan Project of the Huaihua city, CN [grant numbers 2021R3114, 2021R3115]; the School-level Scientific Research Project of Jishou University, CN [grant numbers Jdzd21041]."